Pure Global

Glioblastoma Psychosocial Support Program - Trial NCT06038604

Access comprehensive clinical trial information for NCT06038604 through Pure Global AI's free database. This phase not specified trial is sponsored by Duke University and is currently Recruiting. The study focuses on Glioblastoma. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06038604
Recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06038604
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Glioblastoma Psychosocial Support Program
Psychosocial Support Program for Patients With Glioblastoma and Their Family Caregivers

Study Focus

Glioblastoma

Psychosocial Support Intervention

Interventional

behavioral

Sponsor & Location

Duke University

Durham, United States of America

Timeline & Enrollment

N/A

Nov 03, 2023

Apr 01, 2024

40 participants

Primary Outcome

Number of participants who complete study participation,Number of participants who complete post-intervention assessment,Participants' satisfaction with treatment

Summary

The goal of the study is to conduct a pilot test of the psychosocial support intervention
 with family caregivers and/or patients coping with glioblastoma.

ICD-10 Classifications

Malignant neoplasm of brain
Malignant neoplasm: Brain, unspecified
Mesothelioma
Malignant neoplasm: Brain stem
Malignant neoplasm: Overlapping lesion of brain

Data Source

ClinicalTrials.gov

NCT06038604

Non-Device Trial